Cn /En

News Center

——

Company news

Industry news

What is unique about the InnoModels Biotechnology CDX platform?

Author:

InnoModels

Release time:

2024-07-08

In the vast field of biomedical research and clinical treatment, the innovation and development of modeling platforms are crucial for advancing scientific research, accelerating the development of new drugs, and realizing personalized treatment. Against this backdrop, InnoModels Biotechnology (Beijing) Co., Ltd. has become a leader in the industry with its unique CDX (Cancer-Derived Xenograft) platform. In this article, we will discuss the unique features of the CDX platform and how it provides strong support for cancer research and clinical treatment.
1. Huge tumor cell line library
The first and foremost unique feature of the InnoModels CDX platform is its large tumor cell line library. The platform has over 400 different tumor cell lines covering a wide range of cancer types and subtypes. This diverse collection provides researchers with an extremely rich set of options, ensuring that they are able to select the most appropriate cell lines for their research, thus ensuring the relevance and efficacy of their studies. This large resource library provides powerful data support for cancer research and helps researchers gain a deeper understanding of the complexity and diversity of cancer.
2. Rich Experimental Experience and Technical Support
Another unique feature of InnoModels' CDX platform is its rich experimental experience and technical support. The platform consists of a team of experienced experts who have more than 10 years of experience in the field of CDX modeling. From experienced researchers and QC specialists to project managers, the shared knowledge among the team members ensures the smooth execution of the project. They not only understand the complexities of CDX modeling, but also provide valuable insights into the design and implementation of projects. In addition, the platform is equipped with a variety of advanced inoculation and delivery technologies, such as subcutaneous inoculation, bilateral inoculation (lysovirus), in situ inoculation, etc., as well as multiple routes of delivery, such as i.t (injection into tumor tissue), i.v (intravenous), etc., in order to satisfy the needs of different studies.

3. Strict quality control process and research team
InnoModels' CDX platform attaches great importance to the integrity and compliance of experimental data. They adopt a strict QC process to ensure that all cells are tested for STR (Short Tandem Repeat) and Mycoplasma and Chlamydia to ensure the purity and quality of the cells. In addition, they are committed to performing RNAseq or other similar tests on the selected cells to ensure that the mutations and expression of the desired targets are as expected. In terms of the scientific team, the InnoModels Biotechnology CDX platform is led by PhDs with extensive industry experience who are committed to providing scientific support for each project. Whether it's guidance on experimental design, problem solving, or data interpretation, the team of experts ensures that research projects run smoothly.
4. Advanced in vivo imaging and in situ inoculation technology
InnoModels Biotechnology CDX platform also adopts advanced in vivo imaging and in situ inoculation technologies. With the firefly luciferase (Luc)-labeled CDX model, researchers can perform in situ inoculation with in vivo imaging monitoring. This technology helps researchers observe tumor growth and metastasis, as well as drug distribution and efficacy in the body in real time. In addition, in situ inoculation technology can also more accurately simulate the growth environment of tumors in the human body, providing a more clinically relevant experimental platform for drug development and personalized treatment.
5. High portability and wide application prospects
One of the major advantages of InnoModels' CDX platform is its high portability. By transplanting the patient's cancer tissues into mice and other animals to form human-derived xenograft tumors, CDX technology retains the heterogeneity and complexity of the original tumor tissues. This makes the CDX model highly applicable in drug development. Researchers can use this model to systematically evaluate the effects of different drugs on tumors and accelerate the process of new drug development. In addition, CDX technology is widely used in the research of various cancer types, such as breast cancer, lung cancer, colorectal cancer, etc., providing a universal tool for interdisciplinary cancer research.
In conclusion, with its unique features such as a large tumor cell line library, rich experimental experience and technical support, strict quality control process and research team, advanced in vivo imaging and in situ inoculation technology, as well as high portability and wide application prospects, the InnoModels Biotechnology CDX platform has demonstrated a strong competitiveness in the field of cancer research and clinical treatment. In the future, with the continuous development and innovation of the technology, the InnoModels Biotechnology CDX platform is expected to provide more effective treatment solutions for cancer patients and make greater contributions to human health.

InnoModels Biotechnology ADCC platform: what are the key features

InnoModels Biotechnology: Immunogenicity Testing Platform for New Drug Development

InnoModels Biotechnology ADCC platform: what are the key features

InnoModels Biotechnology: Immunogenicity Testing Platform for New Drug Development

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License